Anakinra in COVID-19: important considerations for clinical trials
Andrew T. King, Andy Vail, Claire O’Leary, Cathal John Hannan, David Brough, Hiren C. Patel, James Galea, Kayode Ogungbenro, Megan Wright, Omar Pathmanaban, Sharon Hulme, Stuart M. Allan
Topics & Concepts
MedicineCytokine stormAnakinraARDSPneumoniaImmunologyCoronavirus disease 2019 (COVID-19)Macrophage activation syndromeTocilizumabInternal medicineDiseaseLungInfectious disease (medical specialty)COVID-19 Clinical Research StudiesAutoimmune and Inflammatory Disorders ResearchLong-Term Effects of COVID-19